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Introduction
Bleeding is a common complication of antithrombotic treatments 
of acute coronary syndrome (ACS), and invasive procedures are one 
of the important risk factors of bleeding.
1)2) Contrast media (CM) and 
heparin are used during coronary angiography (CAG) and play a role 
as anticoagulants.
3) The reported overall bleeding rate in patients 
with ACS undergoing percutaneous coronary intervention (PCI) is 
18.1%, and that of major bleeding after CAG is 2.7%.
4) In patients 
with ACS, bleeding is usually associated with increased mortality, 
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arachnoid hemorrhage (SAH) is one of the major bleeding events 
that can but rarely occur after CAG, extravasation of the CM by dis-
ruption of the blood-brain barrier (BBB) after CAG can sometimes 
mimic acute SAH on brain computed tomography (CT).
6) We report 
a patient who developed SAH just after CAG with non-ionic CM and 
a minimal dose of heparin. 
Case
A 55-year-old man with a history of acute ST elevation myocar-
dial infarction (STEMI) was admitted for a follow-up CAG. He was 
taking antihypertensive medication and did not have a history of 
neurologic disease or hemorrhagic disorder. He was admitted to 
the hospital due to STEMI of inferior wall which was 1 year before. 
Emergent CAG showed total occlusion of the right coronary artery 
at the middle portion (Fig. 1A). Primary PCI was performed, and in-
tracoronary thrombi were aspirated during the PCI. A TAXUS Liber-
té paclitaxel-eluting coronary stent® (3.0×24 mm, Boston Scientific 
Co., Natick, MA, USA) was implanted in the middle portion of the 
right coronary artery. During the procedure, we injected 100 mL of io-
dixanol (Visipaque®, GE Healthcare Co., Ireland Cork, Ireland), which 
is a nonionic CM, and 3000 IU of unfractionated heparin. There were 
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abnormalities as well. He was started on aspirin, clopidogrel, carve-
dilol, cilazapril, pitavastatin and isosorbide mononitrate. 
After 15 months, the patient was readmitted for the follow-up CAG. 
He had an alert mental state, without any symptoms or signs at ad-
mission. His blood pressure was 130/80 mm Hg and his heart rate 
was 80 beats per minute. Flattened T wave and pathologic Q wave 
were identified on the inferior leads of the electrocardiography (ECG), 
and isolated ventricular premature complex was seen on ECG. Com-
plete blood count indicated 15.5 gm/dL of hemoglobin and 153000/ 
mm
2 platelets. The prothrombin time (international normalized ra-
tio 1.06) and the activated partial thromboplastin time (36.1 sec-
onds), serum creatinine (0.9 mg/dL), aspartate aminotransferase and 
alanine aminotransferase (18 IU/L and 18 IU/L, respectively) were 
all within normal range. Right radial arterial puncture was performed 
for the CAG, and no evidence of in-stent restenosis was demonstrat-
ed (Fig. 1B). Unfractionated heparin (1000 IU) was used for the lu-
minal coating of the 5 French Judkin catheters and 70 mL of iodixa-
nol was used for CAG. At the end of the CAG, the patient complain-
ed of neck stiffness and nausea with vomiting. He showed an alert 
mental state, and the pupil reflexes were prompt and isocoric. How-
ever, weaknesses in both lower extremities (motor grade IV) was noted.
Emergent non-contrast brain CT was performed. Diffusely in-
creased density (maximum 65 Hounsfield units) was found in all 
cisternal spaces, including the Sylvian fissure (Fig. 2A). Small am-
ount of intraventricular and intracranial hemorrhage of the left po-
sterior lobe and the periventricular white matter were also seen. 
Additionally, cerebral angiography was performed using 100 mL of 
iodixanol. Vascular malformation or aneurysm was not detected 
A   B  
Fig. 1. Angiographic findings of the right coronary artery. A: totally occluded right coronary artery at the initial coronary angiography for primary percuta-
neous coronary intervention. B: patent previous TAXUS Liberté stent on follow-up coronary angiography performed 15 months later.
A   C   B  
Fig. 2. Initial brain CT shows. A: diffuse acute subarachnoid hemorrhage (maximum 65 HU) in the basal, interpeduncular, ambient and both lateral cisterns. 
B and C: CT scan shows almost complete resolution of the acute SAH after 2 days. SAH: subarachnoid hemorrhage.199 Min Seok Oh, et al.
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on the digital subtraction angiography. However, the patient be-
came stuporous and showed sluggish pupil reflexes. He was trans-
ferred to the neurosurgery ward and was referred to the surgical 
intensive care unit (SICU). We discontinued aspirin and clopidogrel, 
and intravenous sodium valproate, tranexamic acid, mannitol and 
nicardipine were administered. After 24 hours in the SICU, the pa-
tient was in lethargic mental state with dysarthria and motor weak-
ness was partially recovered. Transcranial Doppler ultrasound ex-
amination failed, due to a poor acoustic window. Follow-up brain CT 
(48 hours after the CAG) showed that the SAH had improved re-
markably (Fig. 2B and C).
Two weeks after the event, brain magnetic resonance imaging 
(MRI) with angiography was performed. A remnant subacute stage 
SAH (high signal on both T1- and T2-weighted images) in the supra-
vermian cistern, the posterior fossa (medulla level), the right central 
sulcus and a small amount of intraventricular hemorrhage remain-
ed, but were shrunken compared to previous images. A steno-occlu-
sive lesion or aneurysm was not detected on MR angiography (Fig. 3). 
The patient was returned to the general ward and aspirin was re-
started on the 21st day. He was improved to an alert mental state 
and dysarthria was recovered gradually. The patient was discharged 
from the hospital on the 28th day after admission and is still alive 
after 12 months. However, mild sensory impairment in his right 
arm still exists. 
Discussion
Subarachnoid hemorrhage is a life-threatening major bleeding af-
ter angiography associated with multi-systemic symptoms.
7) How-
ever, neurotoxicity of the CM (i.e. leakage of CM in the subarachnoid 
space) can sometimes mimic an acute SAH.
6) We report a case of 
SAH after CAG that was initially confused with neurotoxicity of CM. 
Clotted blood may have a slightly higher attenuation in the range 
of 45-100 Hounsfield unit (HU).
4) Blood typically has a maximal 
range of 40-60 HU (100% blood by volume has an attenuation of 66 
HU.)
8) Only 50% or less is reabsorbed from the subarachnoid space 
within 24 hours in SAH.
9) The maximal HU of CM is more than 90 on 
a brain CT.
10)
Contrast media-induced neurotoxicity has been reported as tran-
sient and rapidly reversible.
4) The disruption of the BBB may cause 
extravasation of the CM after CAG, which may mimic acute SAH.
5) 
The neurotoxicity of CM can occur especially when using ionic high 
osmolar agents, but does not happen frequently.
11) In general, non-
ionic CM has a lower incidence of neurotoxic events than ionic 
CM.
12) Non-ionic CM, such as iodixanol, has been reported to cause 
transient cortical blindness, confusion and amnesia, but no focal de-
ficits, whereas ionic CM develops more severe complications, in-
cluding seizures and motor and speech deficits.
3)13)14) Although it is 
hard to discriminate CM leakage clinically, hyperdense signal on 
both T1 and T2 weighted MRI images can be helpful in the diagno-
sis of late subacute SAH.
15)
In this presented case, equivocal HU on the initial brain CT and ra-
pid clearance of the hyperdensity on follow-up images were not di-
agnostic. Similarly, sustained neurologic symptoms were not consis-
tent with direct neurotoxicity of CM. Subacute SAH was confirmed 
on MRI images 2 weeks after the initial event. 
When using CM, the pathophysiology of bleeding is not clear in 
patients. CM has been shown to act as anticoagulant through pro-
longation of the in vitro bleeding time;
2)16) however, non-ionic CM 
has a smaller effect on bleeding tendencies than ionic CM.
16) The ad-
A   C   B  
Fig. 3. Two weeks after the SAH, magnetic resonance (MR) image shows hyperdense material in the supravermian cistern on both T1 (A) and T2 (B) 
weighted images (arrows), suggesting remnant subacute SAH. The MR angiogram reveals no evidence of aneurysm in the major intracranial vessels (C). 
SAH: subarachnoid hemorrhage.200  Subarachnoid Hemorrhage Mimicking Leakage of Contrast Media
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ministered CM dosage and concentration did not exceed those re-
commended for CAG (as indicated by the manufacturer) and the pa-
tient had no renal function impairment. In addition, the total amount 
of heparin used during the CAG was minimal; therefore, the possi-
bility of a heparin-induced SAH was relatively low. The anticoagula-
tory effects of iodixanol may play an additional role in the cause of 
SAH. The anticoagulation effects of both heparin and iodixanol may 
have been summative in this case. 
Most cases of SAH are caused by rupture of an intracranial aneu-
rysm. The incidence of SAH was 15 to 20% in patients without a vas-
cular lesion on cerebral angiography, and up to 24% of all SAH pa-
tients with initial negative angiography have an aneurysm found 
on repeat angiography.
17) Sickle cell disease, bleeding disorders, pitu-
itary apoplexy, trauma, cocaine abuse, spinal aneurysm, brain tumor, 
reversible vasoconstriction syndrome and reversible posterior leu-
koencephalopathy syndrome have been reported as possible causes 
of SAH, rather than vascular lesion.
1)18) Although vascular cause was 
ruled out by MR angiography and conventional cerebral angiogra-
phy, we could not exclude the microaneurysm and vasoconstric-
tion syndrome in this case. A cerebrospinal fluid analysis might be 
helpful to distinguish blood from CM.
6)19)
Acute SAH is a rare but possible complication after coronary artery 
intervention with a minimal dose of heparin and CM.
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